Sakai H, Tsurutani J, Ozaki Y, Ishiguro H, et al. A randomized, double-blind, placebo-controlled phase II study of olanzapine based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtec Ann Oncol 2024 Sep 5:S0923-7534(24)03995-4. doi: 10.1016/j.annonc.2024.
PMID: 39284382